Education
About Us
Working with TipRanks
Follow Us
Bluejay Diagnostics (BJDX)
NASDAQ:BJDX
Total Valuation
Bluejay Diagnostics has a market cap or net worth of $1.85M. The enterprise value is -$4.17M.
Market Cap$1.85M
Enterprise Value-$4.17M
Share Statistics
Bluejay Diagnostics has 972,215 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding972,215
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bluejay Diagnostics’s return on equity (ROE) is -1.15 and return on invested capital (ROIC) is -113.98%.
Return on Equity (ROE)-1.15
Return on Assets (ROA)-0.96
Return on Invested Capital (ROIC)-113.98%
Return on Capital Employed (ROCE)-1.16
Revenue Per Employee0.00
Profits Per Employee-978.35K
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bluejay Diagnostics is ―. Bluejay Diagnostics’s PEG ratio is 0.00181.
PE Ratio―
PS Ratio0.00
PB Ratio0.20
Price to Fair Value0.20
Price to FCF-0.19
Price to Operating Cash Flow-0.14
PEG Ratio0.00181
Income Statement
In the last 12 months, Bluejay Diagnostics had revenue of 0.00 and earned -6.85M in profits. Earnings per share was -15.25.
Revenue0.00
Gross Profit-170.68K
Operating Income-6.95M
Pretax Income-6.85M
Net Income-6.85M
EBITDA-6.78M
Earnings Per Share (EPS)-15.25
Cash Flow
In the last 12 months, operating cash flow was -6.05M and capital expenditures -173.74K, giving a free cash flow of -6.23M billion.
Operating Cash Flow-6.05M
Free Cash Flow-6.23M
Free Cash Flow per Share-6.41
Dividends & Yields
Bluejay Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change-88.33%
50-Day Moving Average2.61
200-Day Moving Average5.45
Relative Strength Index (RSI)34.77
Average Volume (3m)5.27M
Important Dates
Bluejay Diagnostics upcoming earnings date is Apr 16, 2025, Before Open (Confirmed).
Last Earnings DateNov 7, 2024
Next Earnings DateApr 16, 2025
Ex-Dividend Date―
Financial Position
Bluejay Diagnostics as a current ratio of 4.88, with Debt / Equity ratio of 2.17%
Current Ratio4.88
Quick Ratio4.88
Debt to Market Cap0.10
Net Debt to EBITDA0.74
Interest Coverage Ratio-8.29K
Taxes
In the past 12 months, Bluejay Diagnostics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bluejay Diagnostics EV to EBITDA ratio is 0.57, with an EV/FCF ratio of 0.62.
EV to Sales0.00
EV to EBITDA0.57
EV to Free Cash Flow0.62
EV to Operating Cash Flow0.64
Balance Sheet
Bluejay Diagnostics has $5.16M in cash and marketable securities with $129.56K in debt, giving a net cash position of $5.04M billion.
Cash & Marketable Securities$5.16M
Total Debt$129.56K
Net Cash$5.04M
Net Cash Per Share$5.18
Tangible Book Value Per Share$13.31
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bluejay Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast97.70%